Evidence for novel non-angiogenic pathway in breast-cancer metastasis

F. Pezzella, M. Manzotti, A. Di Bacco, G. Viale, A. G. Nicholson, R. Price, C. Ratcliffe, U. Pastorino, K. C. Gatter, A. L. Harris, D. G. Altman, S. Pilotti, U. Veronesi

Research output: Contribution to journalArticle

Abstract

We have reported that angiogenic primary breast carcinoma can relapse not only as angiogenic, but also as non-angiogenic, lung metastases. This non-angiogenic pathway seems to be a novel pathway of cancer progression, and such tumours are likely to be resistant to antiangiogenic treatment.

Original languageEnglish
Pages (from-to)1787-1788
Number of pages2
JournalLancet
Volume355
Issue number9217
Publication statusPublished - May 20 2000

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Evidence for novel non-angiogenic pathway in breast-cancer metastasis'. Together they form a unique fingerprint.

  • Cite this

    Pezzella, F., Manzotti, M., Di Bacco, A., Viale, G., Nicholson, A. G., Price, R., Ratcliffe, C., Pastorino, U., Gatter, K. C., Harris, A. L., Altman, D. G., Pilotti, S., & Veronesi, U. (2000). Evidence for novel non-angiogenic pathway in breast-cancer metastasis. Lancet, 355(9217), 1787-1788.